THE Consumers Health Forum of Australia (CHF) has welcomed the reduction of the maximum co-payment under the Pharmaceutical Benefits Scheme (PBS) to $25 from January 2026, a move that has gained bipartisan support from Labor and the Coalition.
CHF CEO Dr Elizabeth Deveny said it is a major win for Australian health consumers and something CHF has consistently advocated for.
“Every dollar matters w...
